Order Article Reprints

Garcia KS, de Azevedo MFC, Carlos AdS, Barros LL, Oba J, Sobrado Junior CW, Sipahi AM, Alves ODdC, Navarro-Rodriguez T, Parra RS, et al. Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial. Biomedicines. 2023; 11(6):1757. https://doi.org/10.3390/biomedicines11061757

Garcia, Karoline Soares, Matheus Freitas Cardoso de Azevedo, Alexandre de Sousa Carlos, Luísa Leite Barros, Jane Oba, Carlos Walter Sobrado Junior, Aytan Miranda Sipahi, Olívia Duarte de Castro Alves, Tomás Navarro-Rodriguez, Rogério Serafim Parra, and et al. 2023. "Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial" Biomedicines 11, no. 6: 1757. https://doi.org/10.3390/biomedicines11061757

Garcia, K. S., de Azevedo, M. F. C., Carlos, A. d. S., Barros, L. L., Oba, J., Sobrado Junior, C. W., Sipahi, A. M., Alves, O. D. d. C., Navarro-Rodriguez, T., Parra, R. S., Chebli, J. M. F., Chebli, L. A., Flores, C., Vieira, A., do Ceará, C. D. A., Queiroz, N. S. F., & Damião, A. O. M. C. (2023). Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial. Biomedicines, 11(6), 1757. https://doi.org/10.3390/biomedicines11061757